No trading action warranted, this is a standard ownership reporting requirement with no indication of buying, selling, or material change in holdings.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 2 $5.27entry
- T+1 · 8mo ago +0.95%α +0.47% · $5.32
- T+5 · 7mo ago −3.23%α −6.84% · $5.10
- T+20 · 7mo ago +14.99%α +5.11% · $6.06
- T+60 · 5mo ago +60.91%α +46.75% · $8.48
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Susan R. Salka, a reporting owner at Teladoc Health, filed a Form 3 to report her initial beneficial ownership of securities and appointed attorneys-in-fact to handle future SEC filings on her behalf. This is a routine regulatory filing with no material financial implications.
Key Facts
- Susan R. Salka filed a Form 3 to report initial beneficial ownership of Teladoc Health securities
- She granted power of attorney to Adam C. Vandervoort, Jonathan Dorfman, and Seth Lowinger to file Forms 3, 4, and 5 on her behalf
- The filing was submitted on April 1, 2026, with a reporting period as of March 30, 2026
- No transaction details or share amounts were disclosed in the available documents
Financial Impact
No financial impact, this is a procedural filing with no disclosed transactions or share quantities
Risk Factors
- None identified, this is a routine compliance filing
- Lack of disclosed share amounts limits ability to assess potential future insider activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001158584-26-000007 |
| Document: 0001158584-26-000007-index-headers.html | 0001158584-26-000007 |
| Document: 0001158584-26-000007-index.html | 0001158584-26-000007 |
| Document: 0001158584-26-000007.txt | 0001158584-26-000007 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers